AC Immune Partner Genentech to Start Second Phase 3 Clinical Trial For Alzheimer s Therapy Crenezumab

Tuesday, February 28, 2017 1 min read

Key Takeaway: AC Immune Partner Genentech to Start Second Phase 3 Clinical Trial For Alzheimer s Therapy Crenezumab

Full Press Release Details

AC Immune Partner Genentech to Start Second Phase 3 Clinical Trial For Alzheimer s Therapy Crenezumab.